| Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis MK Frey, MD Ahsan, H Bergeron, J Lin, X Li, RK Fowlkes, P Narayan, ... Journal of Clinical Oncology 40 (35), 4129-4143, 2022 | 51 | 2022 |
| Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer P Narayan, J Flynn, Z Zhang, EF Gillespie, B Mueller, AJ Xu, J Cuaron, ... Scientific reports 11 (1), 12781, 2021 | 27 | 2021 |
| Polymer-surfactant nanoparticles for improving oral bioavailability of doxorubicin AR Kirtane, P Narayan, G Liu, J Panyam Journal of Pharmaceutical Investigation 47, 65-73, 2017 | 24 | 2017 |
| Bevacizumab in advanced endometrial cancer MM Rubinstein, S Dickinson, P Narayan, Q Zhou, A Iasonos, W Ma, ... Gynecologic oncology 161 (3), 720-726, 2021 | 16 | 2021 |
| Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis MD Ahsan, SR Levi, EM Webster, H Bergeron, J Lin, P Narayan, ... PEC innovation 2, 100138, 2023 | 10 | 2023 |
| What happens in the long term: Uptake of cancer surveillance and prevention strategies among at‐risk relatives with pathogenic variants detected via cascade testing MK Frey, MD Ahsan, N Badiner, J Lin, P Narayan, R Nitecki, ... Cancer 128 (24), 4241-4250, 2022 | 8 | 2022 |
| Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival P Narayan, CE Kostrzewa, Z Zhang, DAR O’Brien, BA Mueller, JJ Cuaron, ... Breast Cancer Research and Treatment 199 (2), 355-361, 2023 | 3 | 2023 |
| Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis. P Narayan, MD Ahsan, EM Webster, L Perez, SR Levi, B Harvey, I Wolfe, ... Gynecologic Oncology 177, 72-85, 2023 | 2 | 2023 |
| Association of the Duffy-null allele and endometrial cancer characteristics: An effort to explore racial disparity in Black women with endometrial cancer. EM Webster, R Martini, A Kulkarni, P Narayan, M Chao, E Cantillo, ... Journal of Clinical Oncology 41 (16_suppl), 5603-5603, 2023 | 2 | 2023 |
| Cascade testing for hereditary cancer syndromes: Should we move towards direct relative contact? A systematic review and meta-analysis (384) MD Ahsan, H Bergeron, J Lin, R Fowlkes, P Narayan, R Nitecki, ... Gynecologic Oncology 166, S196, 2022 | 1 | 2022 |
| Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypes DM McKean, Q Zhang, P Narayan, SU Morton, V Strohmenger, VT Tang, ... The Journal of Clinical Investigation 134 (11), 2024 | | 2024 |
| Genetics and etiology of congenital heart disease. P Narayan, F Richter, S Morton Current Topics in Developmental Biology 156, 297-331, 2024 | | 2024 |
| Cascade genetic testing in racial and ethnic minorities: Are we Leaving them out? A systematic review and meta-analysis (2130) N Nguyen, MD Ahsan, E Webster, S Levi, J Lin, P Narayan, X Li, ... Gynecologic Oncology 176, S215-S216, 2023 | | 2023 |
| A pilot study evaluating somatic mutational burden and signatures among endometrial cancer patients: Is there prognostic benefit to whole genome sequencing? A Kulkarni, R Martini, EM Webster, P Narayan, M Chao, E Cantillo, ... Journal of Clinical Oncology 41 (16_suppl), e17629-e17629, 2023 | | 2023 |
| EP272/# 1143 Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: a systematic review and meta-analysis P Narayan, M Ahsan, S Beaumont, J Lin, L Perez, L Bull, I Wolfe, ... International Journal of Gynecologic Cancer 32 (Suppl 3), 2022 | | 2022 |
| Relative disclosure of information on hereditary cancer syndromes: A systematic review and meta-analysis. MD Ahsan, H Bergeron, J Lin, P Narayan, BB Nelson, X Li, C Thomas, ... Journal of Clinical Oncology 40 (16_suppl), 10592-10592, 2022 | | 2022 |
